Corona Remedies IPO GMP surges pre-debut; experts offer listing strategies

• Corona Remedies IPO will debut on Monday after being subscribed 137 times, raising Rs 655 crore.
• The IPO's price band was Rs 1,008–1,062 per share, with Rs 195 crore secured from anchor investors.
• Grey Market Premium (GMP) for Corona Remedies shares is 27-30%, suggesting significant listing gains.
• Experts advise short-term investors to book partial profits, while long-term investors can hold due to the company's steady performance and growth in key segments.

Why It Matters: Investors get insights on Corona Remedies IPO's listing gains and strategies.